Vasculitis refers to a group of disorders that cause inflammation in your blood vessels. It’s also called angiitis or arteritis. It can cause your blood vessels to become weak, dilated, enlarged, or constricted. Damage to organs and tissues may occur if blood flow is restricted.
Vasculitis has several subtypes, most of which are infrequent. One or more organs may be impacted by vasculitis. Long-term or transient conditions are also possible. Although vasculitis may affect anyone, some forms are more prevalent in particular age groups. The majority of subtypes need medicine to reduce inflammation and minimize flare-ups.
It is unclear what causes vasculitis exactly. Several subtypes are influenced by genetics. Others happen when the immune system unintentionally attacks blood vessel cells. Possible triggers for this immune system reaction include:
The majority of vasculitis types often manifest the following common signs and symptoms:
In accordance with the body parts affected, other signs and symptoms include:
Tests and procedures include –
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
Belzutifan Plus Pembro Approved for Adjuvant RCC
2.
Palliative Care Remains Uncommon in Young Adults With Cancer
3.
Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice
4.
Antitumor mRNA-based vaccines show potential against gastric cancer metastasis
5.
Tumor-targeting fluorescent bacteria illuminate cancer for precision surgery
1.
Personalized Hematology Through Patient-Specific Cellular Profiles
2.
Epigenetic Subtyping of Complex Hematologic Disorders
3.
Risk Assessment of Bone-Marrow Reserve Under Repeated Physiological Demands
4.
Getting to Know RDW and SD: How They Relate to Anemia, Inflammation, and More
5.
Bispecific Antibodies in Hematologic Malignancies: Mechanisms, Clinical Applications, and Future Directions
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
2.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
3.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
4.
How Platelet Disorders Can Affect the Body
5.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation